DHR · News · 20261030N
Guidance / Outlook
DANAHER CORP /DE/ · 2026-10-30 · Importance 51 · Surprise 60 · In source text
Danaher raised its full-year 2026 adjusted diluted EPS outlook to $8.57–$8.62 after third-quarter revenue, adjusted earnings, and cash flow exceeded expectations. The company reported stronger third-quarter performance and accelerated core revenue growth excluding respiratory testing. Danaher expects continued improvement in end markets, while respiratory demand remains a headwind.
Key facts
- Danaher raised its full-year 2026 adjusted diluted EPS guidance to $8.57–$8.62. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | positive | committed | — | Danaher raised its full-year 2026 adjusted diluted EPS guidance to $8.57–$8.62. |